Metabolic Dysfunction–Associated Steatotic Liver Disease in Children and Adolescents
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
This JAMA Insights discusses the diagnosis, treatment, and prognosis of metabolic dysfunction–associated steatotic liver disease in children and adolescents.
Appeared: Friday, October 23. JAMA. Peer-reviewed journal.